INCOG BioPharma Services
PrivateLast Round
Grant
Dec 16, 2025
Total Funding Raised
$57.86M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
INCOG BioPharma Services is a contract development and manufacturing organization (CDMO) that provides end-to-end services for sterile injectable drug products for the global biopharmaceutical market. Founded in 2020, the company supports biopharmaceutical partners from clinical through commercial stages. Its services include injectable drug product formulation, analytical method development, process scale-up, and the filling of vials, syringes, and cartridges. INCOG also offers customized packaging, device assembly, and integrated storage solutions. The company operates out of an FDA-approved, 90,000 sq. ft. facility in Fishers, Indiana, and is actively expanding its capacity to meet growing market demand.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
INCOG BioPharma Services Comparables
Compare INCOG BioPharma Services with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| August Bioservices | 90% | |
| Grand River Aseptic Manufacturing | 88% | |
| Simtra BioPharma Solutions | 88% |
INCOG BioPharma Services Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 16, 2025 | ||||
| Series C | May 29, 2024 | ||||
| Debt | May 10, 2022 | ||||
| Series B | Apr 26, 2022 |
Key People
Founding team and executive leadership
INCOG BioPharma Services Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| City of Fishers | Grant |
| Indiana Economic Development Corporation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 24, 2026
Grew 18% QoQ, from 385 to 456 employees.
- Sep 2, 2026
Grew 26% QoQ, from 348 to 440 employees.
INCOG BioPharma Services Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about INCOG BioPharma Services's valuation, stock price, and market status.
Is INCOG BioPharma Services a public or private company?
INCOG BioPharma Services is a private company.
What is the current stock price of INCOG BioPharma Services?
INCOG BioPharma Services is a private company with no public stock price. Caplight tracks INCOG BioPharma Services's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is INCOG BioPharma Services worth (valuation)?
Valuation information for INCOG BioPharma Services is not publicly available.
Can I buy INCOG BioPharma Services stock?
INCOG BioPharma Services shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was INCOG BioPharma Services's last funding round?
INCOG BioPharma Services's most recent funding round was Grant on December 16, 2025.
Who are the main investors in INCOG BioPharma Services?
Key investors in INCOG BioPharma Services include City of Fishers, Indiana Economic Development Corporation.
Will INCOG BioPharma Services IPO soon?
No public IPO plans have been announced for INCOG BioPharma Services.
How can I track INCOG BioPharma Services secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor INCOG BioPharma Services's secondary market activity and sign up for updates.